Olivier Delannoy

Olivier Delannoy has a diverse work experience spanning across various companies. Olivier currently holds the position of VP, Commercial Excellence and Business Operations, Europe at Amarin Corporation, where they are responsible for implementing an efficient go-to-market model across different European geographies. In their previous role at AstraZeneca, they served as the Global Healthcare Pathway Transformation Lead for Cardiovascular Renal & Metabolic diseases, leading a team to reengineer healthcare pathways and optimize diabetes, heart failure, and chronic kidney disease pathways. Olivier also served as the Global Head of Digital for the same division, developing digital strategies and establishing partnerships for heart failure and chronic kidney disease diagnosis. Prior to that, they held positions such as Head of Global Commercial Effectiveness and Commercial Excellence Director at AstraZeneca, where they set global standards for commercial planning and execution and provided strategic direction for the commercial model in Europe. Olivier also has experience in multichannel marketing, global digital engagement, customer excellence, market research management, and clinical data capture management. Olivier began their career as a Medical Representative at Therabel.

Olivier Delannoy attended Agro Louvain - Faculty of Bioscience Engineering from 1987 to 1992, where they obtained a degree in Engineering with a focus on Crop Science. In 2014, they completed the Senior Leaders course on leading Enterprise Transformation at MIT Sloan School of Management. In 2020, they participated in the Leading Business program at Duke University's Duke Corporate Education.